Treatment with aripiprazole and topiramate in an obese subject with borderline personality disorder, obsessive-compulsive symptoms and bulimia nervosa: A case report

Cases Journal

Volumn 2, Issue 7, 2009, Pages

  Bruno, Antonio ^a   Riganello, Deborah ^a   Marino, Antonio ^a  

^a Institute of Psychiatric Rehabilitation Villa S Agata   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; TOPIRAMATE;

ADULT; ARTICLE; BORDERLINE STATE; BULIMIA; CASE REPORT; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; OBESITY; OBSESSIVE COMPULSIVE DISORDER; PSYCHIATRIC DIAGNOSIS; PSYCHOANALYSIS; PSYCHOLOGIC TEST; PSYCHOTHERAPY; SUPPORT GROUP; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 77953439098     PISSN: 17571626     EISSN: None     Source Type: Journal    
DOI: 10.4076/1757-1626-2-7288     Document Type: Article

References (16)

1. Flewett T, Bradley P, Redvers A: Management of borderline personality disorder. Br J Psychiatry 2003, 183:78-79.
2. Sanislow CA, Grilo CM, Morey LC, Bender DS, Skodol AE, Gunderson JG, Shea MT, Stout RL, Zanarini MC, McGlashan TH: Confirmatory factor analysis of DSM-IV criteria for borderline personality disorder: findings from the collaborative longitudinal personality disorders study. Am J Psychiatry 2002, 159:284-290.
3. Lieb K, Zanarini MC, Schmahl C, Linehan MM, Bohus M: Borderline personality disorder. Lancet 2004, 364:453-461.
4. Díaz-Marsá M, González Bardana S, Tajima K, García-Albea J, Navas M, Carrasco JL: Psychopharmacological treatment in borderline personality disorder. Actas Esp Psiquiatr 2008, 36:39-49.
5. Nickel MK, Muehlbacher M, Nickel C, Kettler C, Pedrosa Gil F, Bachler E, Buschmann W, Rother N, Fartacek R, Egger C, Anvar J, Rother WK, Loew TH, Kaplan P: Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study. Am J Psychiatry 2006, 163:833-838.
6. Nickel MK, Loew TH, Pedrosa Gil F: Aripiprazole in treatment of borderline patients, part II: an 18-month follow-up. Psychopharmacology (Berl) 2007, 191:1023-1026.
7. Nickel M: Treatment of aggression with topiramate in male borderline patients. A double-blind, placebo-controlled study. Biol Psychiatry 2005, 57:495-499.
8. Nickel M, Nickel C: Topiramate treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controlled study. J Clin Psychiatry 2004, 65:1515-1519.
9. Loew T, Nickel M: Topiramate treatment for women with BPD: a double-blind, placebo-controlled study. J Clin Psychopharmacol 2006, 26:61-66.
10. Spurling RD, Lamberti JS, Olsen D, Tu X, Tang W: Changes in metabolic parameters with switching to aripiprazole from another second-generation antipsychotic: a retrospective chart review. J Clin Psychiatry 2007, 68:406-409.
11. Theisen FM, Beyenburg S, Gebhardt S, Kluge M, Blum WF, Remschmidt H, Elger CE, Hebebrand J: A prospective study of body weight and serum leptin levels in patients treated with topiramate. Clin Neuropharmacol 2008, 31:226-230.
12. Hirose T, Uwahodo Y, Yamada S, Miwa T, Kikuchi T, Kitagawa H, Burris KD, Altar CA, Nabeshima T: Mechanism of action of aripiprazole predicts clinical efficacy and favourable side effects. J Psychopharmacol 2004, 18:375-383.
13. Crocq MA, Camus V, Millet B, Gliskman J, Azorin JM, Krebs MO, Limosin F, Costentin J, Daléry J: Clinical potentialities and perspectives for the use of aripiprazole in other disorders than its classical indications. A critical analysis of the recent literature. Encephale 2008, 34:187-193.
14. Stroup TS, Lieberman JA, McEvoy JP, Davis SM, Swartz MS, Keefe RSE, Miller AL, Rosenheck RA, Hsiao JK: Results of phase 3 of the CATIE schizophrenia trial. Schizophr Res 2009, 107:1-12.
15. Landmark CJ: Targets for antiepileptic drugs in the synapse. Med Sci Monit 2007, 13:RA1-RA7.
16. McElroy SL, Hudson JI, Capece JA, Beyers K, Fisher AC, Rosenthal NR: Topiramate for the Treatment of Binge Eating Disorder Associated With Obesity: A Placebo-Controlled Study. Biol Psychiatry 2007, 61:1039-1048.